title: [The X-VeRT study].
authors.affiliation: U.O. Cardiologia Ospedaliera, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari.
authors.forename: Paolo
authors.initials: P
authors.lastname: Colonna
authors.affiliation: U.O. Cardiologia Ospedaliera, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari.
authors.forename: Rossella
authors.initials: R
authors.lastname: Troccoli
authors.affiliation: U.O. Elettrofisiologia e Cardiostimolazione, A.O. Sant'Anna, Como.
authors.forename: Giovanni Luca
authors.initials: GL
authors.lastname: Botto
mesh_terms: D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000628:therapy; D004554:Electric Countershock / Q000379:methods; D004617:Embolism / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D065427:Factor Xa Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006331:Heart Diseases / Q000401:mortality; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D019934:International Normalized Ratio; D008875:Middle Aged; D009025:Morpholines / Q000009:adverse effects / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic / Q000379:methods / Q000706:statistics & numerical data; D009203:Myocardial Infarction / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000706:statistics & numerical data; D012107:Research Design; D012306:Risk; D000069552:Rivaroxaban; D020521:Stroke / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*; D019851:Thrombophilia / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors; D016896:Treatment Outcome; D014812:Vitamin K / Q000037:antagonists & inhibitors; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D014812:Vitamin K; D014859:Warfarin; D000069552:Rivaroxaban